2023 was another particularly tumultuous year for life sciences and, although the lingering effects of the...
OPINION
Experts Point of View
The 2023 State of the Union speech saw biotechnology rise as a priority for the European Union. It has been...
Born with the aim of harmonising the application, evaluation, and supervision process of clinical trials...
Despite the recent stock market rally and declining volatility, IPOs are rather rare in many industrialised...
As cultivated meat moves closer to commercialisation, we are seeing a worrying trend of misinformation...
The Enlarged Board of Appeal (EBoA) of the European Patent Office will decide upon a question of high...